Thinking of joining a study?

Register your interest

NCT05556031 | Not yet recruiting | Heart Failure


Ambulatory Heart Failure Service Model Study
Sponsor:

Chinese University of Hong Kong

Information provided by (Responsible Party):

Professor Bryan Ping Yen YAN

Brief Summary:

The aim of the study is to assess the efficacy of this new ambulatory service model in reducing heart failure hospitalization (HHF), improving clinical as well as functional outcomes of post-discharge patients with Heart Failure of reduced ejection fraction (HFrEF) and Heart failure with preserved Ejection Fraction (HFpEF).

Condition or disease

Heart Failure

Intervention/treatment

Standard care

Study Type : Observational
Estimated Enrollment : 500 participants
Official Title: The Reduction of Decompensation and Unnecessary Cardiac Failure Emergency Admissions: Ambulatory Heart Failure Service Model
Actual Study Start Date : October 2022
Estimated Primary Completion Date : October 2027
Estimated Study Completion Date : January 2028

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Criteria
Inclusion Criteria
  • Dyspnoea (exertional or at rest) and 2 of the following signs:
  • Congestion on chest X-ray
  • Rales on chest auscultation
  • Clinically relevant oedema (e.g. ≥1+ on a 0 to 3+ scale)
  • Elevated jugular venous pressure
  • NT-proBNP ≥300 pg/mL (Patients with AF: NT-proBNP ≥900 pg/mL)
  • Heart failure hospitalization that requires the treatment of a minimum single dose of 40 mg of i.v. furosemide (or equivalent i.v loop diuretics)
  • Ambulatory patients
Exclusion Criteria
  • Cardiogenic shock required inotropics
  • Cardiac mechanical support implantation like LVAD
  • Life expectancy less than 1 year due to underlying significant comorbidities like metastatic cancer or end-stage COPD
  • Haemodynamically severe uncorrected primary cardiac valvular disease planned for surgery or intervention during the course of the study.
  • End stage renal failure or eGFR <15 mL/min/1.73m2 as measured during index hospitalization or requiring dialysis

Ambulatory Heart Failure Service Model Study

Location Details


Please Choose a site



Ambulatory Heart Failure Service Model Study

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Not yet recruiting

Hong Kong,

The Chinese University of Hong Kong

Shatin, Hong Kong, 999077

Loading...